top of page

Key Opinion Leaders: Driving Innovation and Engagement in Healthcare


In a captivating presentation at the COG Nordics meeting in Copenhagen, Adintya Putri, the Clinical Director at AroCell/IDL Biotech AB, shed light on the significance of Key Opinion Leaders (KOLs) in healthcare. Drawing from her extensive experience in clinical project management, Adintya outlined the crucial roles KOLs play in shaping the healthcare landscape.


Adintya Putri, the Clinical Director at AroCell/IDL Biotech AB
Adintya Putri, the Clinical Director at AroCell/IDL Biotech AB

Adintya emphasized that collaborating with established healthcare professionals who are well-known, well-published, and trusted within their therapeutic areas can positively impact brand awareness, reputation, and product acceptance in the market. She highlighted the importance of KOLs as thought leaders, clinical advisors, educators, advocates, and collaborators.


A key takeaway from the presentation was the significance of understanding the patient journey. Adintya stressed that mapping the patient journey is crucial for healthcare organisations seeking to enhance patient experiences and optimize care delivery. By breaking down the journey into stages, identifying touch points, and involving stakeholders, organizations can gain valuable insights and build enduring relationships with relevant stakeholders.


Adintya also provided a step-by-step guide for identifying and engaging with relevant KOLs. She emphasised the importance of research, establishing criteria, and leveraging conferences and social media platforms to connect with experts in specific areas of interest. Collaboration opportunities, such as joint research projects, advisory board participation, and speaking invitations, were also discussed as effective ways to foster meaningful relationships with KOLs.


Adintya's presentation underscored the vital role KOLs play in driving innovation and engagement in clinical trials, and wider healthcare sector. By understanding the patient journey, identifying relevant KOLs, and nurturing collaborative relationships, trial sponsors can enhance their credibility, optimize trial delivery, and ultimately improve patient outcomes.


Adintya Putri, the Clinical Director at AroCell/IDL Biotech AB Presenting
Adintya Putri, the Clinical Director at AroCell/IDL Biotech AB

Missed this one? Join our next European meeting in Amsterdam this November, full details here: https://www.thepbcgroup.com/cog-europe 

留言


bottom of page